BULK DRUG SUBSTANCES AND FDA EVALUATION The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Report: FDA Set to Unban RFK Jr.'s Favorite Peptides FDA Removes Key Peptides from Category 2: What This Means for You HIMS: Regulatory Arbitrage and the Future of Personalized Medicine THE PCCA BLOG FDA Guidance Explained: Compounding with Bulk Dru